| Literature DB >> 34948092 |
Jill A Jenkins1, Katherine R Hartop2, Ghadeer Bukhari2, Debra E Howton2, Kelly L Smalling3, Scott V Mize4, Michelle L Hladik5, Darren Johnson1, Rassa O Draugelis-Dale1, Bonnie L Brown2.
Abstract
Neonicotinoids (NEO) represent the main class of insecticides currently in use, with thiamethoxam (THX) and clothianidin (CLO) primarily applied agriculturally. With few comprehensive studies having been performed with non-target amphibians, the aim was to investigate potential biomarker responses along an adverse outcome pathway of NEO exposure, whereby data were collected on multiple biological hierarchies. Juvenile African clawed frogs, Xenopus laevis, were exposed to commercial formulations of THX and CLO at high (100 ppm) and low (20 ppm) concentrations of the active ingredient. Mortality, growth, development, liver metabolic enzyme activity, and gene expression endpoints were quantified. Tadpoles (n > 1000) from NF 47 through tail resorption stage (NF 66) were exposed to NEO or to NEO-free media treatments. Liver cell reductase activity and cytotoxicity were quantified by flow cytometry. Compared to control reference gene expressions, levels of expression for NEO receptor subunits, cell structure, function, and decontamination processes were measured by RT-qPCR by using liver and brain. Mortality in THX high was 21.5% compared to the control (9.1%); the metabolic conversion of THX to CLO may explain these results. The NF 57 control tadpoles were heavier, longer, and more developed than the others. The progression of development from NF 57-66 was reduced by THX low, and weight gain was impaired. Liver reductases were highest in the control (84.1%), with low NEO exhibiting the greatest reductions; the greatest cytotoxicity was seen with THX high. More transcriptional activity was noted in brains than in livers. Results affirm the utility of a study approach that considers multiple complexities in ecotoxicological studies with non-target amphibians, underscoring the need for simultaneously considering NEO concentration-response relationships with both whole-organism and biomarker endpoints.Entities:
Keywords: Xenopus laevis; biomarkers; flow cytometry; gene expression; liver enzymes; metamorphosis; neonicotinoids
Mesh:
Substances:
Year: 2021 PMID: 34948092 PMCID: PMC8706403 DOI: 10.3390/ijms222413291
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Compilation of results on fish organismal response after exposure to clothianidin or thiamethoxam.
| Common Name | Scientific Name | Biological Endpoint | Media Type | Exposure Concentration of the Active Ingredient (mg L−1) | Observation Duration (Days) | Data Source |
|---|---|---|---|---|---|---|
| Clothianidin | ||||||
| Bluegill sunfish |
| LC50 1; mortality | freshwater | >117 | 4 | EPA #344, 1992 |
| Bluegill sunfish |
| NOEL 2; mortality | freshwater | 117 | 4 | EPA #344, 1992 |
| Fathead minnow |
| LOEC 3; growth | n.d. | 20 | 33 | EPA #344, 1992 |
| Fathead minnow |
| NOEL; growth | n.d. | 9.7 | 33 | EPA #344, 1992 |
| Fathead minnow |
| EC50; intoxication | freshwater | >0.5 | 4 | DePerre et al., 2015 |
| Fathead minnow |
| LC50; mortality | freshwater | >0.5 | 4 | DePerre et al., 2015 |
| Sheepshead minnow |
| NOEL; mortality | saltwater | 93.6 | 4 | EPA #344, 1992 |
| Rainbow trout |
| LC50; mortality | freshwater | >105.8 | 4 | EPA #344, 1992 |
| Rainbow trout |
| NOEL; mortality | freshwater | 105.8 | 4 | EPA #344, 1992 |
| Zebrafish |
| multiple | freshwater | 20.0 | 5 | Padilla et al. 2012 |
| Thiamethoxam | ||||||
| Bluegill sunfish |
| LC50; mortality | freshwater | 114 | 4 | EPA #344, 1992 |
| Bluegill sunfish |
| NOEL; mortality | freshwater | 114 | 4 | EPA #344, 1992 |
| Sheepshead minnow |
| LC50; mortality | salt water | >111 | 4 | EPA #344, 1992 |
| Sheepshead minnow |
| NOEL; mortality | salt water | 111 | 4 | EPA #344, 1992 |
| Rainbow trout |
| LC50; mortality | fresh water | 100 | 4 | EPA #344, 1992 |
| Rainbow trout |
| NOEL; mortality | fresh water | 100 | 4 | EPA #344, 1992 |
| Rainbow trout |
| LC50; mortality | n.d. | >1005 | 4 | Syngenta SDS |
| Rainbow trout |
| LC50; mortality | fresh water | >100 | 4 | EPA #344, 1992 |
| Rainbow trout |
| NOEC 4 | fresh water | 20 | 45 | EPA #344, 1992 |
| Rainbow trout |
| LOEC | n.d. | >20 | 45 | EPA #344, 1992 |
1 LC(50) = 50% lethal concentration in treatment. 2 NOEL = No observable effect level, or the highest exposure level of a substance or material that produces no noticeable toxic effect. 3 LOEC = lowest observed effect concentration different from control. 4 NOEC = No observed effect concentration or highest dose level where no effects are noted.
Target and reference genes, their general cellular function, primer pair sequences a, and size in base pairs.
| Gene (Abbreviation) | Cellular Function | Sequence 5′-3′ | Base Pairs |
|---|---|---|---|
| Reference Genes | |||
| Elongation factor 1-α ( | Delivery of aminoacyl tRNAs to ribosomes | CTG CAC ATA TCG CCT GTA AG | 107 |
| GGC AGC ATC TCC AGA TTT C | |||
| Actin ( | Major protein of contractile apparatus | GGC CGT ACA ACT GGT ATT G | 93 |
| CAT GAT GGC ATG AGG TAA GG | |||
| Ornithine decarboxylase ( | Polyamine biosynthesis pathway | GTA CAA GCT GTC TCA GAT GC | 92 |
| GGG AAT CCA CCA CCA ATA TC | |||
| Glyceraldehyde-3-phosphate dehydrogenase ( | Carbohydrate metabolism | ATC AAG GCC GCC ATT AAG | 115 |
| CAA AGA TGG AGG AGT GAG TG | |||
| Target Genes | |||
| nAcetylcholine receptor subunit α7 ( | Mediating synaptic fast signal transmission | ACC TGA AGT TTG GCT CAT GG | 159 |
| GGT ATG GTT CCT TGC AGC AT | |||
| Muscarinic acetylcholine receptor 4 ( | Mediating synaptic fast signal transmission | ATC TTT ATC GCC ACC GTC AC | 204 |
| GAG TGG CCA GTA ACC CTT GA | |||
| Cytochrome p450 ( | Monooxygenase; detoxification, resistance | AGG AGA AGA GAG TCG ATG | 220 |
| GCT CTG TCT GAT AAT CTA GG | |||
| Acetylcholinesterase ( | Hydrolyses acetylcholine, ends CNS signal | ATC TGA ACT ATA ACC CAC AG | 245 |
| TGT AAT GTT GAG CAG TTT AG |
a Sequence data and descriptions obtained from RefSeq (https://www.ncbi.nlm.nih.gov/refseq/, accessed on 2 December 2021), GenBank (Benson et al., 2009) [84], and XenBase (Karimi et al., 2019) [60]. b Source was per Dickinson and Sive, 2006 [87]. c Primers designed for this study.
Figure 1(A) Average total lengths (SE) of tadpoles (Xenopus laevis) measured incrementally from day 1 to day 44 post-hatch. Tadpoles were exposed in vivaria to thiamethoxam (THX), clothianidin (CLO), or pesticide-free control media. Lengths were measured from photographs of all individuals in each vivarium per treatment group (n = 4 replicate vivaria per treatment group). One asterisk indicates significant difference from control by ANOVA at the day of sampling, and two asterisks indicate significance by ANOVA and MANOVA (days 30 and 44). (B) The difference in tadpole lengths (SE) within treatment groups are plotted relative to control lengths.
Morphometrics (SE) of Xenopus laevis tadpoles at the end of 44 days of exposure to thiamethoxam (THX), clothianidin (CLO), or in neonicotinoid-free media in four replicate vivaria per treatment.
| Treatment | Tadpoles ( | Wet Weight (g) | Total Length (mm) | NF Stage | |||
|---|---|---|---|---|---|---|---|
| Control | 45.8 (4.3) | 0.73 (0.11) | - | 63.18 (2.50) | - | 56.9 (0.33) | - |
| THX 20 ppm | 69.5 (3.2) | 0.39 (0.03) |
| 48.22 (1.22) |
| 54.2 (0.18) |
|
| THX 100 ppm | 68.3 (3.9) | 0.52 (0.07) | 0.204 | 52.12 (2.91) |
| 54.5 (0.59) |
|
| CLO 20 ppm | 52.0 (3.4) | 0.56 (0.04) | 0.245 | 54.00 (1.56) |
| 55.3 (0.43) |
|
| CLO 100 ppm | 44.8 (4.1) | 0.62 (0.10) | 0.334 | 53.79 (1.86) |
| 55.7 (0.35) | 0.054 |
a Average tadpole number in the four replicate vivaria per treatment group. b Bold is significant by ANOVA with Holm-Sidak multiple comparison method, α = 0.05, comparing treatments with control.
Figure 2The progression of developmental stages of Xenopus laevis tadpoles during metamorphosis from the Nieuwkoop and Faber stages NF 57–66 in thiamethoxam (THX), clothianidin (CLO), or neonicotinoid-free control treatment groups. Each dot is the mean per one of four replicate vivaria. Solid lines were plotted after applying a two-parameter logistic growth model of developmental stage data from NF 57–66. The THX 20 ppm (low concentration) was depressed compared to that of the control group (p = 0.004).
Comparison of Xenopus laevis tadpole development a in treatment groups compared with controls in neonicotinoid-free media as measured on day 44 and on day 76. Tadpoles were exposed to low or high concentrations of clothianidin (CLO) and thiamethoxam (THX).
| Treatment | Difference b in NF (95% Confidence Interval) | |
|---|---|---|
| NF 57; day 44 | Post-metamorphosis (NF 66; day 76) | |
| CLO 20 ppm |
|
|
| CLO 100 ppm |
| 1.16 (0.97, 1.34) |
| THX 20 ppm |
| 1.08 (0.96, 1.20) |
| THX 100 ppm |
| 1.12 (0.99, 1.25) |
a Developmental staging by Nieuwkoop and Faber (NF) (Gurdon, 1995). b Difference is defined as the NF of the control minus the NF of the experimental treatment value. c Bold indicates significance at p < 0.001.
Figure 3Cumulative mortality at days 44 and 76 of Xenopus laevis tadpoles exposed to thiamethoxam (THX) and clothianidin (CLO) treatments at high (100 ppm) and low (20 ppm) concentrations compared with that from neonicotinoid-free media. Differences among treatment groups at both days were noted, with control treatment mortality lower than THX high (p = 0.0007). Numbers within bars indicate the average mortality percentages. A different letter within a day group implies significance.
Figure 4Representative flow cytometric cytograms from analysis of liver cells from 5 pooled organs (n = 3 replicates per treatment group) from Xenopus laevis tadpoles following exposure to neonicotinoids. (A) Debris is gated out at the origin, with 31.0% of intact, large cells further analyzed. (B,C) Reductases from cells from thiamethoxam 100 ppm (THX high) and clothianidin at 20 ppm (CLO low) indicate more metabolically active cells apparent in the THX high (63.9%) than the CLO low (37.3%), and higher levels of dead cells in THX high (B,D) with CLO lo showing a predominance of injured rather than dead cells (C). (D,E) Cells in the injured/dead gate are displayed in histogram format with the geometric means of green fluorescence (FL1-H) clearly showing higher values in THX high (1312) than in the CLO low treatment group (144). Data were collected 24 h after tadpoles were removed from the treatment.
Figure 5Flow cytometric data on the proportion of reductase activity and the cytotoxicity of the dead and injured cell populations from livers of Xenopus laevis tadpoles exposed for 44 days in neonicotinoid-free control media, or in either thiamethoxam (THX) or clothianidin (CLO) treatment groups at 20 and 100 ppm, or low and high, respectively. From 3 to 7 flow cytometric analyses were performed on 5 livers pooled per treatment (n = 24 total analyses). Data were collected 24 h after tadpoles were removed from the treatment and placed into neonicotinoid-free media. Letters represent differences among treatment groups per bar color (reductase activity, p < 0.0001; cytotoxicity, p = 0.0129).
Figure 6Gene expression levels of target genes muscarinic acetylcholine receptor 4 (chrm4), nicotinic acetylcholine receptor subunit α7 (chrna7), acetylcholinesterase (ache), cytochrome P450 (cyp1a1), and actin (act) in Xenopus laevis tadpole liver and brain tissues following exposure to thiamethoxam (THX) and clothianidin (CLO) at 20 and 100 ppm, or low and high, respectively, at 44 days. Target gene expressions were normalized to those from tadpoles in the control neonicotinoid-free treatment by using geometric means of both odc and gapdh reference genes; expression of chrm4 was normalized to odc only. Asterisks denote values differing significantly from the pesticide-free treatment per tissue type.
Compilation of results on amphibian survival after exposure to clothianidin or thiamethoxam 1.
| Common Name | Scientific Name | Life Stage | Exposure Concentration (ug/L) | Duration (Days) | Mortality | Data Source |
|---|---|---|---|---|---|---|
| Clothianidin | ||||||
| Northern leopard frogs |
| tadpole | 0–100 | 56 | no | Robinson et al., 2021 |
| Northern leopard frogs |
| tadpole | 428 ± 66 | 14 | no | Gavel et al., 2021 |
| Northern leopard frogs |
| tadpole | 2.5 and 250 | on order | no | Robinson et al., 2019 |
| Wood frogs |
| tadpole | 2.5 and 251 | on order | no | Robinson et al., 2020 |
| Thiamethoxam | ||||||
| Northern leopard frogs |
| tadpole | 0–100 | 56 | no | Robinson et al., 2021 |
| Northern leopard frogs |
| tadpole | 304 ± 49 | 14 | no | Gavel et al., 2021 |
| Northern leopard frogs |
| tadpole | 2.5 and 250 | on order | no | Robinson et al., 2019 |
| Wood frogs |
| tadpole | 2.5 and 251 | on order | no | Robinson et al., 2020 |
| Wood frogs |
| tadpole | 1, 10, 100 | 42 | no | Robinson et al., 2017 |
| Wood frogs |
| tadpole | 200–25,200 | 14 | n.a. | Pochini and Hoverman, 2017 |
1 Commercial formulations may have been employed.